Endothelial dysfunction is associated with diverse cardiovascular pathologies. Here, we show a previously unappreciated role for the Abelson (Abl) family kinases (Abl and Arg) in endothelial function and the regulation of angiogenic factor pathways important for vascular homeostasis. Endothelial Abl deletion in Arg-null mice led to late-stage embryonic and perinatal lethality, with mutant mice displaying focal loss of vasculature and tissue necrosis. Loss of Abl kinases led to increased endothelial cell apoptosis both in vitro and in vivo, contributing to vascular dysfunction, infarction, and tissue damage. Mechanistically, we identify a unique dual role for Abl kinases in the regulation of angiopoietin/Tie2 protein kinase signaling. Endothelial Abl kinases modulate Tie2 expression and angiopoietin-1-mediated endothelial cell survival. These findings reveal a critical requirement for the Abl kinases in vascular development and function, which may have important implications for the clinical use of Abl kinase inhibitors.
Abl tyrosine kinases | heart defects | fibrosis | thrombosis D isruption of vascular homeostasis plays a key role in pathological conditions including atherosclerosis, cancer, diabetes mellitus, and inflammatory arthritis (1, 2) . Endothelial function is regulated, in part, by a variety of vascular growth factors, including vascular endothelial growth factor (VEGF) and the angiopoietins (Angpt) (3) . These factors signal through receptor tyrosine kinases to support endothelial cell proliferation, survival, migration, and vascular stability. The angiopoietins, of which Angpt1 and Angpt2 are best characterized, signal through the Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domains-2) receptor. Angpt1 is the primary Tie2 stimulatory ligand, whereas Angpt2 functions as a context-dependent Tie2 antagonist or agonist (4, 5) . Although VEGF signaling is necessary for initial vasculogenesis, angiopoietin signaling is important for subsequent vascular remodeling as well as for interaction of the endothelium with supporting mural cells (6, 7) . Vascular growth factor signaling also functions to maintain homeostasis in the quiescent vasculature (8, 9) . Thus, delineating the intracellular signaling mechanisms that mediate endothelial responses to these factors has important implications for understanding vascular homeostasis as well as cardiovascular diseases.
The Abl family of nonreceptor tyrosine kinases, which includes the Abl (Abl1) and Arg (Abl2) kinases, has roles in diverse cellular processes, including proliferation, survival, adhesion, and migration (10) . These kinases are activated transiently and mediate cytoskeletal remodeling downstream of several growth factor receptors and following cadherin and integrin engagement (10, 11) . Abl is activated constitutively as a result of the t(9;22) chromosomal translocation that produces the BCR-ABL1 fusion protein, the causal agent in chronic myelogenous leukemia (CML) (12) . Global Abl/Arg-null mice die by embryonic day 10.5 (E10.5), exhibiting hemorrhage and pericardial edema, suggesting a role for these kinases in vascular development (13) . It was reported that long-term treatment with imatinib (Gleevec/ STI571), a pharmacological inhibitor of the Abl kinases (as well as Kit and the platelet-derived growth factor receptor) caused severe congestive heart failure in a subset of CML patients (14) . This cardiotoxicity was attributed to Abl inhibition in cardiomyocytes, leading to endoplasmic reticulum stress and cell death. Similarly, global Abl deletion (C57BL/6J genetic background) led to cardiomyocyte dysfunction, heart enlargement, and perinatal lethality (15) . However, cardiomyocyte-specific restoration of Abl expression did not rescue viability, suggesting a critical role for Abl kinase in additional cell types. Notably, several case reports of patients treated with the second-generation BCR-ABL1 kinase inhibitor nilotinib have detailed the occurrence of vascular occlusive events (16, 17) , suggesting potential vascular dysfunction following Abl kinase inhibition. In vitro studies have demonstrated a requirement for the Abl kinases in mediating both endothelial barrier-promoting effects of sphingosine-1-phosphate and barrier-disrupting effects of VEGF and inflammatory mediators (18, 19) . However, the role of the Abl kinases in the endothelium has not yet been examined using genetic models.
Here, we demonstrate a crucial role for the Abl kinases in the vasculature, using endothelial Abl knockout mice. Loss of endothelial Abl kinases resulted in lethality at late embryonic and perinatal stages of development, with focal regions of vascular loss and tissue necrosis/apoptosis. Further, we demonstrate increased endothelial cell apoptosis in these embryos, as well as in Abl/Arg-knockdown endothelial cells in vitro. Notably, our studies reveal an unexpected link to angiopoietin/Tie2 signaling, with loss of endothelial Abl kinases leading to decreased Tie2 expression, diminished Tie2 receptor signaling, and loss of Angpt1-mediated survival. Further, we find that Abl kinases are activated by Angpt1/ Tie2 signaling. Together, these findings reveal bidirectional signaling linking Abl kinases and Tie2, which is critical for endothelial cell survival and function.
Results
Embryonic Lethality of Abl ECKO ; Arg −/− Mice. To evaluate the vascular function of the Abl kinases, we generated mice with endothelial inactivation of the Abl kinase by crossing mice carrying a floxed Abl allele (Abl flox/flox mice) on an Arg −/− background to Tie2-Cre mice. A near-complete loss of both Abl mRNA and protein was observed in endothelial cells of both embryos and adult mice (Fig. S1 A-D) . No Cre-mediated recombination or Abl depletion was observed in nonendothelial/nonhematopoietic cells ( Fig. S1 B-D) . Strikingly, loss of the endothelial Abl kinases resulted in significant lethality. Most endothelial Abl/Arg-null pups (Abl 
Arg
−/− or mutant) died at birth, with 90% mortality by the end of postnatal day 1 (Fig. 1A) . Further, the total number of Abl ECKO ; Arg −/− mice born was reduced (6.5%) compared with the expected Mendelian ratio (12.5%), suggesting that ∼50% died during embryonic development. Although mutant embryo viability largely was unaffected at earlier stages of cardiovascular development, a decreased number of Abl ECKO ; Arg −/− embryos was observed at later stages (E17.5-E18.5), and mutant embryo viability Author contributions: E.M.C. and A.M.P. designed research; E.M.C. and C.R. performed research; E.M.C. analyzed data; and E.M.C. wrote the paper.
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was decreased (Fig. 1B) . Surviving late-stage mutant embryos were indistinguishable from wild-type (Abl flox/flox ; Arg
) littermates, with no defects in gross vascular morphology (Fig. S1E ). In addition, no changes in overall vascular patterning were observed in the heart or lungs (Fig. S1 F and G) , nor was smooth muscle cell coverage of vessels affected (Fig. S1H) . However, over 50% (42 of 77) of Abl ECKO ; Arg −/− embryos displayed focal areas of hepatic necrosis of varying severity, typically localized to the periphery of the lobes ( Fig. 1 C and D) . Costaining of liver sections for the endothelial marker CD31 [platelet endothelial cell adhesion molecule (PECAM-1)] and apoptosis marker cleaved caspase-3 showed dramatic reduction in vascular density and extensive apoptosis in the peripheral necrotic areas (Fig. 1E) , suggesting a loss of vascular perfusion in these regions.
As Tie2-Cre also drives Abl inactivation in hematopoietic cells, we additionally examined hematopoietic progenitor cells in mutant fetal livers. No differences in percentages of lineagenegative (Lin − )/Kit + hematopoietic progenitors or erythroid marker TER-119/CD71 double-positive progenitors were observed in mutant embryos compared with wild-type littermates (Table S1) . Thus, together our data suggest that loss of Abl kinases in endothelial cells results in lethality linked to loss of vascular function late in development. Arg +/− ; Tie2-Cre −/− littermate controls) and displayed dramatic cardiovascular phenotypes by 2-3 mo of age. The hearts of these mice were enlarged, typically with prominent dilation of the left atrium ( Fig. 2 A and B) . Histological analysis of cardiac tissue sections demonstrated localized regions of collagen deposition and scarring in the left ventricle (Fig. 2C) . Although overall capillary density in the heart and skeletal muscle of Abl ECKO ; Arg +/− mice was not significantly different from Arg +/− controls ( Fig. S2 A and B) , a near-complete loss of blood vessels was observed in the scarred regions (Fig. 2D) . These findings are consistent with the localized loss of vasculature observed in the livers of Abl ECKO ; Arg −/− embryos ( Fig. 1E ) and suggest a critical role for the Abl kinases in vascular maintenance and function. Interestingly, these Abl ECKO ; Arg +/− mice also displayed thickening of the right ventricular wall, which correlated with cardiomyocyte hypertrophy (Fig. S3 A and B) . (20), we examined the lungs of Abl ECKO ; Arg +/− mice. The lungs of these mice were enlarged and dense, with prominent white fibrous areas (Fig. S3  C and D) . Histological analysis of pulmonary structure showed extensive interstitial fibrosis (Fig. S3E) , along with fibrin deposition in the airways (Fig. S3 F and G) , indicating prior hemorrhage and defective pulmonary vascular integrity. We also observed a dramatic loss of vascular density, as assessed by staining for the endothelial marker von Willebrand factor (vWF) (Fig. S3G ). An abundance of hemosiderin-laden macrophages was detected in the lungs of Abl ECKO ; Arg +/− mice (Fig. S3H) ; the presence of these cells has been associated with heart failure (21). Thus, defective left ventricular function may contribute to the observed lung abnormalities, by producing congestion of the lung vasculature, with resulting leakage of red blood cells. Interestingly, no overt cardiac and pulmonary phenotypes were observed in E18. S5 A and B) , and no cardiac hypertrophy or pulmonary fibrosis was observed in (Fig. S4 C-G (Fig. S6A) , and the platelet marker CD41 (integrin αIIb) (Fig. S6B) . Importantly, these thrombi were observed in mice without any outward cardiac pathology, suggesting that their occurrence is not a secondary effect of compromised cardiac function. Histological analysis revealed abnormally swollen endothelial cells adjacent to a lung thrombus (Fig. S6C , Right), consistent with endothelial injury contributing to thrombosis. These findings suggest that loss of Abl kinases perturbs vascular function as a result of endothelial cell damage or death.
Cardiac Enlargement and Scarring in

Increased Apoptosis Following Loss of Endothelial Abl Kinases.
Global Abl/Arg knockout mice displayed increased apoptosis in all tissues (13) , suggesting that the Abl kinases may have an important prosurvival function. Thus, we examined whether loss of Abl kinases affected endothelial cell viability in vivo. Indeed, a significant increase in cleaved caspase-3-positive cells, as well as numerous CD31/cleaved caspase-3 double-positive endothelial cells, was observed in Abl ECKO ; Arg −/− embryo lungs ( Fig. 3 A-C), demonstrating that loss of endothelial Abl kinases led to increased apoptosis. This finding is consistent with the extensive apoptosis detected in Abl ECKO ; Arg −/− embryo livers (Fig. 1E ). To confirm that the observed endothelial cell apoptosis represented a cell-autonomous phenotype, we examined the role of the Abl kinases in endothelial cell survival in vitro. Treatment of primary human umbilical vein endothelial cells (HUVECs) with the Abl pharmacological inhibitor imatinib decreased cell viability and increased levels of apoptosis following serum starvation (Fig. 3 D-F). The prosurvival effects of both VEGF and basic fibroblast growth factor (bFGF) also were decreased in the presence of the Abl inhibitor. Treatment with either VEGF or bFGF led to increased Abl kinase activation, as assessed by the phosphorylation of CrkL at Y207, an Abl-specific phosphorylation site (22) Fig. S7C ), whereas Angpt1 mRNA levels were decreased (Fig. S7D) . No consistent difference in Tie1 receptor expression was observed in cells lacking Abl kinases (Fig. S7B) . Importantly, decreased levels of Tie2 protein also were observed in Abl ECKO ; Arg −/− embryo liver tissue (Fig.  4C) , as well as in liver endothelial cells from E18.5 Abl ECKO ; Arg −/− embryos (Fig. 4D ), whereas VEGF receptor 2 levels were unchanged (Fig. 4C) (Fig. S7E) .
To evaluate the physiological consequences of Tie2 downregulation in endothelial cells lacking Abl kinases, we examined the activation of downstream cellular signaling pathways. As expected, treatment of control HUVECs with angiopoietin-1 led to tyrosine phosphorylation of the Tie2 receptor, along with activation of Akt and Erk pathways (Fig. 5 A and B) ; activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway is required for Angpt1-mediated survival (25). Notably, the Abl kinases also were activated following Angpt1 treatment, as evidenced by increased phospho-CrkL (Y207) levels (Fig. 5A, lanes 1 and 7) . Abl kinase activation also was observed following Angpt1 stimulation of both immortalized human microvascular endothelial cells (HMVECs; Fig. S8A, lanes 1 and 4) and polyoma middle T antigen (PyMT)-immortalized mouse embryo endothelial cells (Fig. S8B, lanes 1-6) . These findings suggest a potential role for the Abl/Arg kinases in mediating downstream Tie2 signaling. In this regard, activation of Akt by Angpt1 was dramatically reduced in Abl/Arg-knockdown cells (Fig. 5A, lanes 7-9) . Erk activation also was decreased to a lesser extent by Abl/Arg depletion. Similarly, Abl/Arg knockdown diminished Angpt1-mediated Akt activation in HMVECs, whereas Erk activation was unchanged (Fig. S8A, lanes 4-6) . Importantly, although Angpt1 inhibited apoptosis following serum starvation in control HUVECs, the prosurvival effects of Angpt1 were decreased in Abl/Arg knockdown cells (Fig. 5C ). Thus, down-regulation of Tie2 receptor levels following Abl/Arg knockdown decreased both Angpt1-mediated signaling and downstream antiapoptotic responses. Single Abl and Arg knockdowns demonstrated that loss of either kinase was sufficient to impair both Angpt1-mediated signaling livers, quantified at Right (means ± SD, normalized to CD31 levels, n = three mice per genotype). *P < 0.05; **P < 0.01; ***P < 0.001. S8C ) and survival (Fig. S8D) . Interestingly, expression of exogenous Tie2 in Abl/Arg-knockdown cells largely restored Angpt1-mediated signaling (Fig. 5A, lanes 10-12) and partially rescued the antiapoptotic effects of Angpt1 (Fig. 5C ). These findings suggest that the increased apoptosis observed upon loss of Abl kinase expression may partly be the result of downregulation of Tie2 signaling.
Discussion
Our findings have uncovered a crucial role for the endothelial Abl kinases in the vasculature, as loss of endothelial Abl/Arg kinase expression resulted in embryonic and perinatal lethality. Loss of endothelial Abl kinases had an adverse impact on vascular function, resulting in localized loss of vascular density and resultant cell death in affected tissues (necrosis/apoptosis). Interestingly, even partial loss of endothelial Abl kinase expression produced focal loss of cardiac vasculature and myocardial injury. The localized nature of the observed vascular loss and tissue damage, along with the normal overall vascular density, branching, and patterning observed in Abl ECKO ; Arg −/− mice, suggests that loss of endothelial Abl/Arg kinases likely adversely affects vascular maintenance and stability, rather than vessel formation. Given that Tie2-Cre-mediated recombination occurs in most endothelial cells by E9.5 (26), it is possible that subtle structural defects during vessel formation might contribute to the phenotypes observed later in development in mutant embryos. However, our finding that loss of the Abl kinases sensitizes endothelial cells to stress-induced apoptosis in vitro suggests that the sporadic and focal nature of the observed phenotypes may result from vascular damage due to localized endothelial apoptosis in response to cumulative vascular stresses in the absence of the Abl kinases. Our demonstration of a critical requirement for the Abl kinases in the vasculature is particularly notable considering the cardiotoxicity previously observed in a subset of patients upon chronic Abl kinase inhibition using imatinib (14, 27, 28) . Additional case reports detail instances of interstitial lung disease of unknown origin in some imatinib-treated cancer patients (29). Although the incidence of these events appears low and imatinib generally is well tolerated, our findings demonstrate a crucial role for the Abl kinases in normal vascular development and function, which may have implications for the clinical use of Abl kinase inhibitors such as imatinib and nilotinib.
Unexpectedly, the current study also reveals bidirectional links between the Abl kinases and angiopoietin/Tie2 signaling in the endothelium. Loss of endothelial Abl/Arg kinase expression decreased Tie2 receptor levels and led to a shift in angiopoietin levels, with enhanced Angpt2 levels and decreased Angpt1 levels. Consequently, loss of Abl kinases decreased Angpt1/Tie2 signaling and diminished the prosurvival effects of Angpt1. Our finding that Abl kinases are activated following Angpt1 stimulation supports a dual role for Abl kinases in the regulation of angiopoietin/Tie2 signaling, through the control of receptor/ligand expression, as well as the modulation of downstream prosurvival signaling pathways (Fig. 5D) . Loss of Tie2 impairs endothelial cell survival in vivo (23). Angpt1/Tie2 signaling also supports vascular stability and inhibits inflammatory endothelial barrier dysfunction and adhesion molecule expression (30). Taken together, our findings support an important role for the Abl kinases in Angpt1/Tie2-mediated vascular homeostasis. As alterations in the angiopoietin/Tie2 pathway have been implicated in diverse vascular pathologies (31-33), a potential role for the Abl family kinases in modulating Tie2 signaling during the progression of these disorders merits further investigation.
Materials and Methods
Additional experimental details are provided in SI Materials and Methods, including reagents and procedures for endothelial cell culture and viability/ apoptosis assays, isolation and characterization of mouse endothelial and fetal liver cells, viral transduction, immunohistochemistry, immunoblotting, and real-time PCR analysis. Endothelial Cell Viability/Apoptosis Assays. Primary HUVECs (5 × 10 3 cells per well in 96-well plates) were cultured in serum-free medium [endothelial basal medium-2 (EBM-2) with 0.2% BSA] for 24-48 h. Some cells were supplemented with either VEGF (100 ng/mL) or basic FGF (bFGF; 10 ng/mL). Abl kinases were inhibited by treatment with imatinib (10 μM). Cell viability in triplicate samples was assessed using CellTiter assay (Promega). In separate experiments, cells were lysed after 24-h serum starvation and cleaved caspase-3 levels were examined by Western blotting. HUVECs expressing control microRNA (miRNA) or Abl/Arg miRNAs were serum starved for 24 h (96 h post miRNA infection). Caspase activity was assessed in triplicate samples using the Caspase-3/7-Glo assay (Promega) and normalized to total cell number. For Angpt1-mediated survival experiments, 200 ng/mL Angpt1 (C-terminal 6-His tag) was preincubated with 20 μg/mL anti-polyhistidine cross-linking antibody for 1 h at 37°C in serum-free medium before treatment of HUVECs.
Generation of Abl
Inhibitors and Reagents. Imatinib (Gleevec/STI571) was a generous gift from Novartis. Recombinant human vascular endothelial growth factor (VEGF-A-165), recombinant human angiopoietin-1 (C-terminal 6-His tag), and anti-polyhistidine cross-linking antibody were purchased from R&D Systems. Recombinant human bFGF was purchased from Invitrogen.
Antibodies. Antibodies used for immunohistochemistry included CD31 (BD Biosciences), von Willebrand factor (vWF) and fibrin/ fibrinogen (Dako), CD41 (eBioscience), α-smooth muscle actin (Sigma), and cleaved caspase-3 (Cell Signaling). Antibodies used for Western blotting included cleaved caspase-3, phospho-CrkL (Y207), VEGF receptor 2 (VEGFR2, anti-human), phosphoAkt(S473), Akt, and phospho-Erk(T202/Y204) from Cell Signaling; β-tubulin from Sigma-Aldrich; Arg (9H5), Angpt2, VEGFR2 (anti-mouse, Flk-1), Erk, lamin B, and CrkL from Santa Cruz; anti-Abl (clone 8E9) from BD Biosciences; and phospho-Tie2(Y992) (tyrosine kinase with immunoglobulin and epidermal growth factor homology domains-2) from R&D Systems. Mouse monoclonal antibody (Ab33) against Tie2 was a gift from Christopher Kontos (Duke University) (2).
Mouse Endothelial Cell Isolation, Flow Cytometric Analysis, and
Characterization of Abl Inactivation. E13.5 embryos (wild-type or Abl ECKO ; Arg −/− ) were disrupted by trituration and digested in 1 mg/mL collagenase A solution (in low-glucose DMEM, supplemented with 1% penicillin-streptomycin, gentamicin, and 25 μg/mL DNase I) for 45 min at 37°C. The cell suspension was then disrupted by passage (20 times) through a syringe with an attached 14-gauge cannula and filtered through a 70-μm cell strainer, followed by red blood cell lysis. Cells were incubated first for 15 min on ice with anti-CD16/CD32 mouse Fc block (BD Biosciences), followed by staining for 30 min with antibodies against CD105, CD45, and CD31 (all from eBioscience) or appropriate isotype control antibodies. After washing twice, cells were subjected to FACS and CD105
− /CD31 + endothelial cells were collected. Retrovirus expressing polyoma middle T antigen (PyMT) was used for endothelial cell immortalization (3). For flow cytometric analysis of endothelial cells, livers from E18.5 embryos (wild-type or Abl ECKO ; Arg −/− ) were similarly digested to a single-cell suspension, then labeled with antibodies against CD31, CD45, and Tie2 (CD202b; eBioscience) or appropriate isotype controls. Expression of each marker was evaluated by flow cytometry, and Tie2 receptor levels were examined in CD31
− endothelial cells using FlowJo software (TreeStar Inc.). Endothelial cells were similarly isolated from hearts and livers from adult control and Abl ECKO ; Arg +/− mice, along with CD105
− nonendothelial/nonhematopoietic cells. Cells were used directly for RNA isolation without culturing. Oligo (dT) 12-18 -primed cDNAs were used for PCR with the following primers-Abl Flox/Δ (forward): 5′-GCC CTG GCC AGA GAT CCA TC-3′, (reverse): 5′-TCC CTC AGG TAG TCC AGC AGG-3′; Abl exon 5 (forward): 5′-GTA CGT GTC CTC CGA GAG CC-3′, (reverse): 5′-CCT TCA GGA ACT CCT CCA CC-3′; Cre (forward): 5′-CGA TGC AAC GAG TGA TGA GG-3′, (reverse): 5′-CGC ATA ACC AGT GAA ACA GC-3′; β2M (forward): 5′-ACC GGC CTG TAT GCT ATC CAG AAA-3′, (reverse): 5′-GGT GAA TTC AGT GTG AGC CAG GAT-3′. The Abl Flox/Δ primers bind to sites within abl exons 4 and 6, respectively; the unrecombined abl flox allele yields a 500-bp PCR product, whereas a recombined abl Δ allele (lacking exon 5) yields a PCR product of ∼200 bp (4).
Flow Cytometry Analysis of Fetal Liver Cells. Livers were isolated from E15.5 wild-type and Abl ECKO ; Arg −/− embryos. Livers were maintained in Hank's Balanced Salt Solution without calcium or magnesium, supplemented with 10% (vol/vol) heat-inactivated FBS and 2 mM EDTA, and were dissociated by gentle trituration. The resulting cell suspension was filtered through 70-μm and 40-μm cell strainers. Approximately 10 6 cells were used for surface staining of hematopoietic markers. Cells were first incubated with anti-CD16/CD32 mouse Fc block (BD Biosciences), followed by staining with antibodies against Kit and hematopoietic lineage markers (TER-119, GR1, B220, CD3, CD4, and CD8a) or erythroid markers (CD71 and TER-119) or appropriate isotype controls (all from eBioscience). After washing, cells were analyzed by flow cytometry and expression of cell surface markers was evaluated using FlowJo software (TreeStar Inc.).
Histological Analysis and Immunohistochemistry. Freshly dissected mouse organs were imaged using a Zeiss Lumar.V12 stereoscope. For routine histology, mouse tissue samples were fixed in 4% (wt/vol) paraformaldehyde and embedded in paraffin; 5-μm sections were used for H&E, Masson trichrome, and Prussian blue staining, following standard protocols. Images were acquired using a Zeiss Axio Imager and MetaMorph software. For FITC-wheat germ agglutinin (WGA) staining, sections were dewaxed and rehydrated, followed by proteinase K treatment (100 μg/mL, 10 min at room temperature). Slides were washed with PBS, then incubated with FITC-WGA (Sigma; 10 μg/mL, 2 h at room temperature). For immunohistochemical analysis, tissue samples were infiltrated with 30% (wt/vol) sucrose (in PBS), then freshfrozen in tissue-freezing medium (Tissue-Tek O.C.T.; Sakura Finetek); 10-μm sections were fixed/permeabilized in ice-cold acetone, blocked in 5% (vol/vol) normal goat serum, and stained overnight at 4°C with the indicated antibodies. Sections were then stained with Alexa Fluor-conjugated secondary antibodies (Invitrogen) and counterstained with Hoechst 33342 (0.5 μg/ mL). Images were acquired using a Zeiss Axiovert 200M fluorescence microscope and AxioVision software. Viral Transduction. pLNCX vector and pLNCX/hTie2 retroviral constructs (kindly provided by Christopher Kontos, Duke University) were transfected into 293T cells, along with pCL10A1 packaging vector, using FuGENE6 reagent (Promega). Retroviral supernatants were collected and filtered 48 h post transfection. HUVECs were incubated 16-24 h with retroviral medium in the presence of 6 μg/mL Polybrene. Cells were cultured at least 2 d in 400 μg/mL geneticin selection medium or sorted for Tie2 overexpression by FACS (mouse anti-hTie2 antibody; BioLegend) before miRNA lentiviral infection. Lentiviral miRNAmediated knockdown of Abl/Arg in HUVECs was conducted as described previously (5, 6) . miRNA targeting sequences were as follows: control miRNA (GGTGTATGGGCTACTATAGAA); Abl miRNA (GGTGTATGAGCTGCTAGAGAA); Arg miRNA #1 (CCTTATCTCACCCACTCTGAA); Arg miRNA #2 (AGG-TACTAAAGTGGCTCTGAG). HUVECs were lysed for Western blotting or used for RNA isolation 96 h post miRNA infection. In vitro Cre-mediated Abl deletion was performed using adenovirus expressing Cre recombinase (Ad5CMVCre-eGFP and Ad5CMV-eGFP control, obtained from the University of Iowa Gene Transfer Vector Core). Primary liver endothelial cells from Abl flox/flox ; Arg
; Tie2-Cre −/− mice were incubated with adenovirus for 8 h at a multiplicity of infection of 200. Lentiviral shRNA transduction was used for Arg knockdown in primary mouse endothelial cells. Lentiviral shRNA plasmid [pLKO.1 vector; the RNAi Consortium (7)] targeting murine Arg was obtained from Open Biosystems (Thermo Scientific), and control (nonspecific) shRNA oligos were cloned into pLKO.1 vector. shRNA sequences (antisense) were as follows: control shRNA (TCGTAAGCCAGATAGTCATGC); Arg shRNA (TTG-AGATAGGTCAATACCTGG). Transduced cells were selected in 1 μg/mL puromycin for at least 2 d.
Lysis and Western Blotting. Cultured cells were lysed in radioimmunoprecipitation assay (RIPA) buffer with protease/phosphatase inhibitors. Alternatively, freshly dissected mouse tissues were flash-frozen in liquid nitrogen, then homogenized in RIPA buffer containing protease/phosphatase inhibitors. Cell/tissue debris was removed by microcentrifugation, and protein concentrations were quantified. Equal amounts of protein were separated by SDS/PAGE and transferred to nitrocellulose membranes. Membranes were probed with the indicated antibodies.
Real-Time RT-PCR Array. RNA was isolated from control or Abl/Argknockdown HUVECs 120 h post miRNA infection, using a Qiagen RNeasy kit. One microgram of each RNA was used for cDNA synthesis, using an RT 2 First Strand cDNA kit (SABiosciences). Gene expression was evaluated using the SABiosciences Human Endothelial Cell Biology Real-Time RT-PCR Array, according to the manufacturer's protocol.
Real-Time RT-PCR Analysis. RNA was isolated from HUVECs using an illustra RNAspin Mini RNA isolation kit (GE Healthcare), and cDNA was synthesized using Oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer and M-MLV reverse transcriptase (Invitrogen). Real-time PCR was performed using iQ SYBR Green Supermix (Bio-Rad). Primers used were as follows-Tie2/Tek (forward): 5′-GGG CTA CAG ACT GGA GAA GC-3′, (reverse): 5′-TGT CAA GGG TCT CCC ATG CC-3′; Tie1 (forward): 5′-ACC CTG GTG TGC ATC CGC AG-3′, (reverse): 5′-GTG ATG TCC TCC CAC TCT AGC-3′; Angpt1 (forward): 5′-ACT GGG AAG GGA ACC GAG CC-3′, (reverse): 5′-TGG AGG GGC CAC AAG CAT CAA-3′; Angpt2 (forward): 5′-GAC ACA CCA CGA ATG GCA TC-3′, (reverse): 5′-CTG AAG GGT TAC CAA ATC CC-3′; RPLP0 (forward): 5′-GGA CAT GTT GCT GGC CAA TAA-3′, (reverse): 5′-GGG CCC GAG ACC AGT GTT-3′. Analysis was performed using a Bio-Rad CFX384 real-time machine and CFX Manager software. PCR assays were performed in triplicate. Expression levels of each gene were normalized to the expression of the RPLP0 ribosomal protein housekeeping control gene. ; Arg −/− embryos for CD31 (red) and α-smooth muscle actin (αSMA, green). Scale bar, 20 μm. *P < 0.05; ***P < 0.001. ; Arg +/− lung. Scale bar, 100 μm. *P < 0.05; ***P < 0.001. , and Arg −/− adult mice, quantified at Right (means ± SD, n = three mice per genotype). *P < 0.05; ***P < 0.01. ; Arg +/+ ; Tie2-Cre −/− adult mice, following in vitro Abl/Arg depletion. Primary liver endothelial cells were infected with either GFP or Cre-GFP-expressing adenoviruses (AdV), followed by lentiviral transduction of either control or Arg shRNAs. Abl, Arg, and Tie2 protein levels (normalized to β-tubulin) are quantified at Right, relative to levels in control knockdown cells (means ± SD, n = 3). *P < 0.05; **P < 0.01; ***P < 0.001.
Legend continued on following page observed. Data are presented as means (%) ± SD (WT, n = five embryos; Abl ECKO ; Arg −/− , n = three embryos).
